bioAffinity Technologies, Inc. cotiza a 3.90 USD y tiene una capitalización bursátil de $5M. En los últimos 12 meses ha facturado $6M con un margen de flujo de caja libre del -152.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory …
| Periodo | 2025-11 | 2025-08 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-4.74 | $-5.10 | — | $-4.80 |
| Estimado | $-2.70 | $-3.00 | $-0.10 | $-4.80 |
| Sorpresa | -75.6% | -70.0% | — | +0.0% |
| Métrica | BIAF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -171.6% | -38.6% | -133.0% |
| Net Margin | -242.0% | -33.6% | -208.4% |
| FCF Margin | -152.4% | -13.9% | -138.5% |
| ROE | -204.9% | -40.4% | -164.5% |
| ROA | -136.0% | -32.0% | -104.0% |
| Current Ratio | 2.60 | 2.84 | -0.24 |
| Debt / Equity | 0.01 | 0.28 | -0.27 |